These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 18172252)

  • 1. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.
    Ying J; Li H; Yu J; Ng KM; Poon FF; Wong SC; Chan AT; Sung JJ; Tao Q
    Clin Cancer Res; 2008 Jan; 14(1):55-61. PubMed ID: 18172252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma.
    Li J; Ying J; Fan Y; Wu L; Ying Y; Chan AT; Srivastava G; Tao Q
    Cancer Biol Ther; 2010 Sep; 10(6):617-24. PubMed ID: 20603606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WNT5A Promoter Methylation Is Associated with Better Responses and Longer Progression-Free Survival in Colorectal Cancer Patients Treated with 5-Fluorouracil-Based Chemotherapy.
    Jiang G; Lin J; Wang W; Sun M; Chen K; Wang F
    Genet Test Mol Biomarkers; 2017 Feb; 21(2):74-79. PubMed ID: 28051879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of Wnt5a, APC, β-catenin and their clinical significance in human colorectal adenocarcinoma].
    Cao YC; Yang F; Liu XH; Xin X; Wang CC; Geng M
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):674-8. PubMed ID: 23159080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles and differential expression levels of Wnt5a mRNA isoforms in colorectal cancer cells.
    Huang TC; Lee PT; Wu MH; Huang CC; Ko CY; Lee YC; Lin DY; Cheng YW; Lee KH
    PLoS One; 2017; 12(8):e0181034. PubMed ID: 28859077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WNT5A, a putative tumour suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukaemia.
    Roman-Gomez J; Jimenez-Velasco A; Cordeu L; Vilas-Zornoza A; San Jose-Eneriz E; Garate L; Castillejo JA; Martin V; Prosper F; Heiniger A; Torres A; Agirre X
    Eur J Cancer; 2007 Dec; 43(18):2736-46. PubMed ID: 18032022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt5a induces endothelial inflammation via beta-catenin-independent signaling.
    Kim J; Kim J; Kim DW; Ha Y; Ihm MH; Kim H; Song K; Lee I
    J Immunol; 2010 Jul; 185(2):1274-82. PubMed ID: 20554957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
    Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
    Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dickkopf-Related Protein 2 is Epigenetically Inactivated and Suppresses Colorectal Cancer Growth and Tumor Metastasis by Antagonizing Wnt/β-Catenin Signaling.
    Wang C; Yue Y; Shao B; Qiu Z; Mu J; Tang J; Han X; Xiang T; Ren G
    Cell Physiol Biochem; 2017; 41(5):1709-1724. PubMed ID: 28365691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients.
    Trifa F; Karray-Chouayekh S; Jmal E; Jmaa ZB; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
    Tumour Biol; 2013 Jun; 34(3):1625-33. PubMed ID: 23417837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
    Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WNT5A gene is aberrantly methylated from the early stages of colorectal cancers.
    Hibi K; Mizukami H; Goto T; Kitamura Y; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Hepatogastroenterology; 2009; 56(93):1007-9. PubMed ID: 19760930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt5a suppresses tumor formation and redirects tumor phenotype in MMTV-Wnt1 tumors.
    Easter SL; Mitchell EH; Baxley SE; Desmond R; Frost AR; Serra R
    PLoS One; 2014; 9(11):e113247. PubMed ID: 25401739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice.
    Bakker ER; Das AM; Helvensteijn W; Franken PF; Swagemakers S; van der Valk MA; ten Hagen TL; Kuipers EJ; van Veelen W; Smits R
    Carcinogenesis; 2013 Nov; 34(11):2629-38. PubMed ID: 23764752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas.
    Li L; Ying J; Tong X; Zhong L; Su X; Xiang T; Shu X; Rong R; Xiong L; Li H; Chan AT; Ambinder RF; Guo Y; Tao Q
    Cell Mol Life Sci; 2014 Jun; 71(11):2179-92. PubMed ID: 24158497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway.
    Hung TH; Hsu SC; Cheng CY; Choo KB; Tseng CP; Chen TC; Lan YW; Huang TT; Lai HC; Chen CM; Chong KY
    Oncotarget; 2014 Dec; 5(23):12273-90. PubMed ID: 25401518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition.
    Cheng R; Sun B; Liu Z; Zhao X; Qi L; Li Y; Gu Q
    J Cell Physiol; 2014 Dec; 229(12):1908-17. PubMed ID: 24464650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of WIF-1 and Wnt5a in patients with colorectal carcinoma: clinical significance.
    Abdelmaksoud-Dammak R; Miladi-Abdennadher I; Saadallah-Kallel A; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
    Tumour Biol; 2014 Aug; 35(8):7975-82. PubMed ID: 24833087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Wnt and β-catenin Expression in Advanced Colorectal Cancer.
    Yoshida N; Kinugasa T; Ohshima K; Yuge K; Ohchi T; Fujino S; Shiraiwa S; Katagiri M; Akagi Y
    Anticancer Res; 2015 Aug; 35(8):4403-10. PubMed ID: 26168479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.